Johns Hopkins Adds Strata’s XTRAC 308 nm Excimer Laser to Clinical Treatments
Johns Hopkins Dermatology has integrated Strata Skin Sciences’ XTRAC 308 nm excimer laser into its clinical programs, joining institutions like NYU and Cleveland Clinic. This expansion underscores growing adoption of precision phototherapy and could boost Strata’s partnership revenue under its fee-per-treatment model.
1. Johns Hopkins Integrates XTRAC Laser
Strata Skin Sciences announced that Johns Hopkins Dermatology has installed the XTRAC 308 nm excimer laser in its clinical program, enabling targeted treatment of psoriasis, vitiligo and atopic dermatitis with precision phototherapy.
2. Expansion of Academic Partnerships
Johns Hopkins joins peers such as New York University, University of California and Cleveland Clinic in adopting XTRAC, reflecting over 300 peer-reviewed studies supporting efficacy in inflammatory and autoimmune skin conditions.
3. Impact on Strata’s Business Model
Under Strata’s partnership program, Johns Hopkins will utilize a fee-per-treatment cost structure for XTRAC services, encompassing equipment use, training, maintenance and co-op advertising support to drive patient volume and revenue growth.